Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    63,608.95
    -738.14 (-1.15%)
     
  • CMC Crypto 200

    1,326.30
    -70.23 (-5.03%)
     
  • S&P 500

    5,107.94
    +59.52 (+1.18%)
     
  • Dow

    38,291.03
    +205.23 (+0.54%)
     
  • Nasdaq

    15,949.88
    +338.12 (+2.17%)
     
  • Gold

    2,347.60
    +5.10 (+0.22%)
     
  • Crude Oil

    83.93
    +0.36 (+0.43%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Why Shares of BioNTech Rose Friday

Why Shares of BioNTech Rose Friday

Shares of BioNTech (NASDAQ: BNTX) were up as by much as 5.3% on Friday before closing the session up 3.85% after the biotech company announced positive news regarding a clinical trial for its non-small cell lung cancer therapy candidate. The company focuses on immunotherapies to treat cancer, infectious diseases, and other diseases. BioNTech's shares have been sliding because sales of Comirnaty, the COVID-19 vaccine it developed with Pfizer, are falling.